The adoptive cell therapy afamitresgene autoleucel (afami-cel) demonstrated a favorable response and duration of response in ...
A new type of immunotherapy shows potential for treating some types of sarcoma — rare cancers of the body’s soft tissues.
This article is Part 2 of our three-part series on MSK-led advances for improving outcomes for patients with rare head and ...
This article is Part 3 of our three-part series summarizing how MSK’s biological insights and expertise fuel innovative ...
MSK psychologist Rosario Costas-Muñiz, PhD, focuses on cancer prevention and treatment in the Latino community, including colorectal cancer. She estimates that 90% of the people she cares for speak ...
Memorial Sloan Kettering Cancer Center (MSK) has a comprehensive and integrated head and neck cancer program with dedicated resources and specialists who treat patients with rare salivary, thyroid, ...
Lung resection after initial nonoperative treatment for non-small cell lung cancer (NSCLC) was safe and led to significantly improved survival in select patients previously treated with nonoperative ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.